Evaluation of a Clinical Pharmacist Intervention on Clinical and Drug-Related Problems Among Coronary Heart Disease Inpatients A pre-experimental prospective study at a general hospital in Indonesia
Journal Title: Sultan Qaboos University Medical Journal - Year 2018, Vol 18, Issue 1
Abstract
Objectives: This study aimed to evaluate the role of a clinical pharmacist intervention in decreasing subsequent clinical and drug-related problems (DRPs) among coronary heart disease (CHD) inpatients with at least one previous DRP. Methods: This pre-experimental study with a pre-post design was carried out from January to April 2017 among inpatients with at least one previous DRP at a general hospital in Tangerang District, Banten, Indonesia. Clinical and DRPs were documented prospectively by a clinical pharmacist, with DRPs classified using Version 6.2 of the DRP classification scheme of the Pharmaceutical Care Network Europe Foundation. The intervention consisted of a discussion of identified DRPs with physicians, patients, pharmaceutical logistics clerks, nurses and nutritionists. Following this, any subsequent clinical and DRPs were re-identified and further interventions were conducted as necessary. Results: A total of 75 inpatients were included in the study. Pre-intervention, there were 443 DRPs and 202 clinical problems. The most frequent DRPs were adverse drug reactions (52.6%), followed by drug effects (41.8%). Most DRPs were of moderate severity and would have resulted in moderate consequences had the pharmacist not intervened. The interventions resulted in a significant reduction in the number of DRPs, type of DRPs and number of clinical problems (P <0.05 each). Patients with complications were 26.047 times more likely to have no reduction or an increased number of clinical problems compared to patients without complications (P <0.05). Conclusion: Clinical pharmacist interventions were found to reduce subsequent DRPs and clinical problems among CHD patients with at least one previous DRP.
Authors and Affiliations
Vina A. Sagita, Anton Bahtiar, Retnosari Andrajati
Keywords
Related Articles
- EP ID EP22862
- DOI 10.18295/squmj.2018.18.01.013
- Views 278
- Downloads 17
Validity of Cardiac Markers as Diagnostic and Prognostic Indicators of Complications in Patients undergoing Percutaneous Coronary Intervention
Te aim of this study was to assess the diagnostic and prognostic value of heart-type fatty acid-binding protein (H-FABP) in elective percutaneous coronary intervention (PCI) and compare it with standard cardiac markers...
Screening of Five Common Beta Thalassemia Mutations in the Pakistani Population A basis for prenatal diagnosis
Talassemia is one of the most common autosomal single-gene disorder worldwide. Te highest prevalence of the disease is in the “thalassemia belt†which includes the Mediterranean region, parts of the Middle East, th...
Nutrigenomics From promise to practice
Continuity of Care Literature review and implications
Continuity of care is widely regarded as a core value of primary care. Te objective of this article is to explore the literature about the concept of continuity of care focusing on factors that influence continuity; adva...
Efficacy and Safety of Selective Laser Trabeculoplasty as a Primary Procedure for Controlling Intraocular Pressure in Primary Open Angle Glaucoma and Ocular Hypertensive Patients
Assessment of the potential efficacy and safety of selective laser trabeculoplasty (SLT) as a primary therapeutic modality for lowering the intraocular pressure (IOP) in high tension open angle glaucoma (OAG) and ocular...